• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Provider AI Strategy Moves From The IT Dept. To The C-Suite

by Syed Hamza Sohail 09/13/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • A new study from Bain & Company and KLAS Research shows US healthcare providers are accelerating spending on IT and software. The research shows nearly 80% of healthcare executives say they increased spending materially over the past year, spurred by emerging technologies—particularly generative AI—labor shortages, and cost pressures.
  • The survey of more than 200 US healthcare provider executives showed nearly 75% are expecting growth in software and technology spending to continue over the next year. These are among the findings of Bain and KLAS’s 2023 Healthcare Provider IT Report.

Key Insights from the 2023 Healthcare Provider IT Report

Academic medical centers (AMCs), as well as large hospitals and health systems, expect a stronger increase in their own spending than smaller operators due to a greater focus on innovation and financial flexibility. Top drivers of new investment include technological advances and the availability of new solutions, particularly around patient engagement and cybersecurity, with intense labor shortages and financial pressures driving spending.

“As AI moves out from the silos of the IT department and into the C-suite agenda, providers are accelerating their investments in IT and tech solutions and looking to streamline their vendor lists,” said Eric Berger, a partner in Bain’s Healthcare & Life Sciences practice. “AI has the power to transform many processes and workflows. However, this shift hinges on the technology’s ability to demonstrate productivity gains in real-world applications without increasing clinical risk. The best vendors will offer AI and other technologies that create clear returns to providers and help mitigate structural challenges facing the US healthcare industry.”

Prioritizing revenue cycle management and clinical workflow optimization

Driven by financial challenges and shrinking margins, the study shows executives prioritize investments in areas with clear, near-term ROIs, such as revenue cycle management (RCM) and clinical workflow optimization software. Patient engagement has moved up the list of priorities, particularly among more advanced or digitally mature providers. In addition to RCM and clinical workflow optimization, the survey found freestanding hospitals and physician groups are prioritizing other core systems, namely electronic health records (EHR) and IT infrastructure. 

Providers want fewer vendors and seamless EHR integration

Providers continue to express a preference for fewer vendors. The survey showed nearly two-thirds of respondents saying they look first to existing vendors, especially electronic health record providers, for new functionality before evaluating new vendors and offerings. While 94% of respondents are open to looking elsewhere if existing vendors lack a solution or have a significant functionality gap, seamless EHR integration is a key purchasing criterion for all healthcare providers evaluating IT solutions.

AI strategy moves from the IT department to the C-suite

Around 70% of health system respondents indicate they believe AI will have a greater impact on their organization than last year, moving AI strategies from the IT department to the C-suite. While only 6% of respondents have a generative AI strategy today, the survey found about 50% of respondents are actively developing a strategy or planning to do so in the near-term. Relative to other provider segments, AMCs lead in AI adoption both today and over the next year. Providers with more advanced AI strategies, especially AMCs, have positive AI sentiments overall due to the potential for greater efficiency, improved patient outcomes, and cost savings.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Generative AI

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |